Overview
Juvenile Parkinson's disease refers to the onset of Parkinson's disease symptoms in individuals under the age of 20, characterized by motor symptoms such as tremor, rigidity, bradykinesia, and postural instability 1.Diagnosis
Clinical evaluation focusing on motor symptoms (tremor, rigidity, bradykinesia, postural instability) 1.
Neuroimaging (MRI) to rule out other conditions 1.
DaTscan (dopamine transporter imaging) to assess dopaminergic neuron loss 1.
Genetic testing in cases with familial patterns 1.Management
First-line treatments: Levodopa (dose individualized, typically starting low and titrating up) 1.
Adjunctive therapies: Dopamine agonists (e.g., pramipexole, ropinirole) to manage motor fluctuations 1.
Symptomatic support: Anticholinergics (e.g., trihexyphenidyl) for tremor control 1.
Physical therapy: Regular exercise programs to maintain mobility and function 1.
Psychosocial support: Counseling and support groups to address psychological impact 1.Special Populations
Pediatrics: Initial multiprofessional inpatient assessment may enhance coping and treatment compliance 1.
Comorbidities: Mental distress in mothers correlates with dissatisfaction and may impact disease management 1.Key Recommendations
Conduct an initial comprehensive inpatient assessment for optimal coping and treatment adherence in juvenile Parkinson's disease (Evidence: Expert opinion) 1.
Utilize Levodopa as first-line therapy, titrating doses based on individual response (Evidence: Expert opinion) 1.
Incorporate dopamine agonists as adjunctive therapy to manage motor complications (Evidence: Expert opinion) 1.References
1 Vandvik IH, Høyeraal HM, Fagertun H. The first stay in a pediatric rheumatology ward. Associations between parent satisfaction and disease and psychosocial factors. Scandinavian journal of rheumatology 1990. link